Brief: Clinuvel Pharmaceuticals Says CFO Darren Keamy Will Conclude Role On 30 June 2024
15/04/2024 02:29
April 15 (Reuters) - Clinuvel Pharmaceuticals Ltd
CUV.AX :
* CFO DARREN KEAMY WILL CONCLUDE HIS ROLE ON 30 JUNE 2024
* PETER VAUGHAN TO REPLACE DARREN KEAMY AS CFO
Further company coverage: CUV.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clinuvel Pharmaceuticals
See all newsBrief: Clinuvel Pharmaceuticals Announces Strategic Reorganisation To Refocus On U.S. Markets
Brief: Clinuvel Pharmaceuticals Ltd's ADS To Commence Trading On Nasdaq
Brief: Clinuvel Pharmaceuticals Says Scenesse Approved For EPP In Canada
Australia's Clinuvel Pharmaceuticals rises on Canada nod for phototoxicity prevention drug
Brief: Clinuvel Pharmaceuticals Updates On Level II ADR Upgrade, Nasdaq Uplist